These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 34441994)
1. Flecainide in Ventricular Arrhythmias: From Old Myths to New Perspectives. Lavalle C; Trivigno S; Vetta G; Magnocavallo M; Mariani MV; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP J Clin Med; 2021 Aug; 10(16):. PubMed ID: 34441994 [TBL] [Abstract][Full Text] [Related]
2. Flecainide How and When: A Practical Guide in Supraventricular Arrhythmias. Lavalle C; Magnocavallo M; Straito M; Santini L; Forleo GB; Grimaldi M; Badagliacca R; Lanata L; Ricci RP J Clin Med; 2021 Apr; 10(7):. PubMed ID: 33918105 [TBL] [Abstract][Full Text] [Related]
3. Flecainide acetate for the treatment of atrial and ventricular arrhythmias. Apostolakis S; Oeff M; Tebbe U; Fabritz L; Breithardt G; Kirchhof P Expert Opin Pharmacother; 2013 Feb; 14(3):347-57. PubMed ID: 23294160 [TBL] [Abstract][Full Text] [Related]
4. Elimination of Benign Ventricular Premature Beats or Ventricular Tachycardia with Catheter Ablation versus Two Different Optimal Antiarrhythmic Drug Treatment Regimens (Sotalol or Verapamil/Flecainide). Haanschoten DM; Vernooy K; Beukema RJ; Szili-Torok T; Ter Bekke RMA; Khan M; de Jong JSSG; Otten AM; Adiyaman A; Smit JJJ; Delnoy PPHM; Ramdat Misier AR; Elvan A Cardiology; 2020; 145(12):795-801. PubMed ID: 32841937 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of class IC antiarrhythmic agents for the treatment of coexisting supraventricular and ventricular tachycardia. Rinkenberger RL; Naccarelli GV; Berns E; Dougherty AH Am J Cardiol; 1988 Aug; 62(6):44D-55D. PubMed ID: 3136636 [TBL] [Abstract][Full Text] [Related]
6. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials. Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638 [TBL] [Abstract][Full Text] [Related]
7. Proarrhythmic Effects Of Antiarrhythmic Drugs: Case Study Of Flecainide Induced Ventricular Arrhythmias During Treatment Of Atrial Fibrillation. Barman M J Atr Fibrillation; 2015 Dec; 8(4):1091. PubMed ID: 27957216 [TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes in patients treated with flecainide for atrial fibrillation with stable coronary artery disease. Burnham TS; May HT; Bair TL; Anderson JA; Crandall BG; Cutler MJ; Day JD; Freedman RA; Knowlton KU; Muhlestein JB; Navaravong L; Ranjan RA; Steinberg BA; Bunch TJ Am Heart J; 2022 Jan; 243():127-139. PubMed ID: 34537183 [TBL] [Abstract][Full Text] [Related]
9. Flecainide: Current status and perspectives in arrhythmia management. Andrikopoulos GK; Pastromas S; Tzeis S World J Cardiol; 2015 Feb; 7(2):76-85. PubMed ID: 25717355 [TBL] [Abstract][Full Text] [Related]
10. The many NOs to the use of Class IC antiarrhythmics: weren't the guidelines too strict? Turturiello D; Cappato R Eur Heart J Suppl; 2022 Nov; 24(Suppl I):I47-I53. PubMed ID: 36380776 [TBL] [Abstract][Full Text] [Related]
11. Safety and utility of flecainide acetate in the routine care of patients with supraventricular tachyarrhythmias: results of a multicenter trial. The Flecainide Supraventricular Tachycardia Study Group. Hopson JR; Buxton AE; Rinkenberger RL; Nademanee K; Heilman JM; Kienzle MG Am J Cardiol; 1996 Jan; 77(3):72A-82A. PubMed ID: 8607395 [TBL] [Abstract][Full Text] [Related]
12. [Estimation of the long-term efficacy of anti-arrhythmia treatment with flecainide in ventricular tachycardia]. Fauchier JP; Cosnay P; Babuty B; Moquet B; Rouesnel P; Estepo J Arch Mal Coeur Vaiss; 1990 Jan; 83(1):77-83. PubMed ID: 2106308 [TBL] [Abstract][Full Text] [Related]
13. Clinical and electrophysiologic assessment of oral flecainide acetate for recurrent ventricular tachycardia: evidence for exacerbation of electrical instability. Oetgen WJ; Tibbits PA; Abt ME; Goldstein RE Am J Cardiol; 1983 Oct; 52(7):746-50. PubMed ID: 6624666 [TBL] [Abstract][Full Text] [Related]
14. Flecainide: electrophysiologic and antiarrhythmic properties in refractory ventricular tachycardia. Platia EV; Estes M; Heine DL; Griffith LS; Garan H; Ruskin JN; Reid PR Am J Cardiol; 1985 Apr; 55(8):956-62. PubMed ID: 3984883 [TBL] [Abstract][Full Text] [Related]
15. [Life-threatening ventricular tachycardia during flecainide treatment for symptomatic atrial fibrillation in a patient with a structural cardiac disorder]. Rienstra M; Wiesfeld AC; van Veldhuisen DJ; van Gelder IC Ned Tijdschr Geneeskd; 2006 May; 150(18):1027-31. PubMed ID: 16715868 [TBL] [Abstract][Full Text] [Related]
16. Use of Flecainide for the Treatment of Atrial Fibrillation. Echt DS; Ruskin JN Am J Cardiol; 2020 Apr; 125(7):1123-1133. PubMed ID: 32044037 [TBL] [Abstract][Full Text] [Related]
17. Proarrhythmic effects of class Ic drugs. Moroe K; Annoura M; Matsuo K; Yamanouchi Y; Kumagai K; Arakawa K Clin Ther; 1993; 15(3):559-66. PubMed ID: 8364947 [TBL] [Abstract][Full Text] [Related]
18. Flecainide: Electrophysiological properties, clinical indications, and practical aspects. Paolini E; Stronati G; Guerra F; Capucci A Pharmacol Res; 2019 Oct; 148():104443. PubMed ID: 31493514 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of flecainide acetate for atrial tachycardia or fibrillation. Berns E; Rinkenberger RL; Jeang MK; Dougherty AH; Jenkins M; Naccarelli GV Am J Cardiol; 1987 Jun; 59(15):1337-41. PubMed ID: 3109229 [TBL] [Abstract][Full Text] [Related]